Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature Medicine 12, 1356 - 1358 (2006)
doi:10.1038/nm1206-1356
Osteoclasts, no longer osteoblast slaves
Brendan F Boyce1 & Lianping Xing1
- The authors are in the Department of Pathology and Laboratory Medicine and the Center for Musculoskeletal Research, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York 14642, USA. e-mail: brendan_boyce@urmc.rochester.edu
Abstract
A protein has been identified that promotes the formation of osteoclasts, bone-degrading cells—while also inhibiting osteoblasts, bone-forming cells. The findings could lead to new avenues of drug development to strengthen bone (pages 1403–1409).
Osteoclasts, bone-degrading cells, operate under the control of osteoblasts, bone-forming cells. But recent studies have suggested that osteoclasts don't just passively carry out orders—they in turn seem to influence osteoblasts1.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Bad bones, grey hair, one mutationNature Medicine News and Views (01 Apr 2003)
Stomaching calcium for bone healthNature Medicine News and Views (01 Jun 2009)
See all 7 matches for News And ViewsRESEARCH
Parametric Images of the Extrastriatal D2 Receptor Density Obtained Using a High-Affinity Ligand (FLB 457) and a Double-Saturation MethodJournal of Cerebral Blood Flow & Metabolism Original Article
Regulation of bone remodeling and emerging breakthrough drugs for osteoporosis and osteolytic bone metastasesKidney International Original Article
See all 8 matches for Research